State-backed Biovac clinches deal with ImmunityBio to make Covid-19 vaccines
If the phase 1 trial demonstrates the vaccine elicits a response, larger phase 2 and 3 trials will be conducted during the year
18 March 2021 - 18:28
State-backed vaccine manufacturer Biovac has entered into a partnership with California-based ImmunityBio for local production of its candidate Covid-19 vaccine, it announced on Thursday.
The agreement is strategically important because it paves the way for Biovac to develop the expertise to manufacture active pharmaceutical ingredients (APIs), said CEO Morena Makhoana...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.